Persistence of zinc-binding bacterial superantigens at the surface of antigen-presenting cells contributes to the extreme potency of these superantigens as T-cell activators

Infection and Immunity

Volumn 73, Issue 9, 2005, Pages 5358-5366

  Pless, Dorothy D ^a,b   Ruthel, Gordon ^a   Reinke, Emily K ^a   Ulrich, Robert G ^a   Bavari, Sina ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b CENTRO DE FÍSICA APLICADA Y TECNOLOGÍA AVANZADA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SUPERANTIGEN; ZINC;

ANTIGEN PRESENTING CELL; ARTICLE; BINDING SITE; CROSS LINKING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGEN-PRESENTING CELLS; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; ENTEROTOXINS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LYMPHOCYTE ACTIVATION; MICROSCOPY, CONFOCAL; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; T-LYMPHOCYTES; ZINC;

EID: 23944468631     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.9.5358-5366.2005     Document Type: Article

References (55)

1. Al-Daccak, R., K. Mehindate, F. Damdoumi, P. Etongue-Mayer, H. Nilsson, P. Antonsson, M. Sundstrom, M. Dohlsten, R. P. Sekaly, and W. Mourad. 1998. Staphylococcal enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with the MHC class II receptors. J. Immunol. 160:225-232.
2. Baker, M. D., and K. R. Acharya. 2004. Superantigens: structure-function relationships. Int. J. Med. Microbiol. 293:529-537.
3. Baker, M., D. M. Gutman, A. C. Papageorgiou, C. M. Collins, and K. R. Acharya. 2001. Structural features of a zinc binding site in the superantigen streptococcal pyrogenic exotoxin A (SpeA1): implications for MHC class II recognition. Protein Sci. 10:1268-1273.
4. Bohach, G. A., D. J. Fast, R. D. Nelson, and P. M. Schlievert. 1990. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit. Rev. Microbiol. 17:251-272.
5. Boles, J. W., M. L. Pitt, R. D. LeClaire, P. H. Gibbs, E. Torres, B. Dyas, R. G. Ulrich, and S. Bavari. 2003. Generation of protective immunity by inactivated recombinant Staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunity. Clin. Immunol. 108:51-59.
6. Burnett, J. C., E. A. Henchal, A. L. Schmaljohn, and S. Bavari. 2005. The evolving field of biodefense: therapeutic developments and diagnostics. Nat. Rev. Drug Discov. 4:281-296.
7. Chiu, I., D. M. Davis, and J. L. Strominger. 1999. Trafficking of spontaneously endocytosed MHC proteins. Proc. Natl. Acad. Sci. USA 96:13944-13949.
8. Coffman, J. D., J. Zhu, J. M. Roach, S. Bavari, R. G. Ulrich, and S. L. Giardina. 2002. Production and purification of a recombinant Staphylococcal enterotoxin B vaccine candidate expressed in Escherichia coli. Protein Expr. Purif. 24:302-312.
9. Davis, J. E., and P. Cresswell. 1990. Lack of detectable endocytosis of B lymphocyte MHC class II antigens using an antibody-independent technique. J. Immunol. 144:990-997.
10. Goldenberg, D. L., and J. I. Reed. 1985. Bacterial arthritis. N. Engl. J. Med. 312:764-771.
11. Gorga, J. C., V. Horejsi, D. R. Johnson, R. Raghupathy, and J. L. Strominger. 1987. Purification and characterization of class II histocompatibility antigens from a homozygous human B-cell line. J. Biol. Chem. 262:16087-16094.
12. Haffner, A. C., K. Zepter, and C. A. Elmets. 1996. Major histocompatibility complex class I molecule serves as a ligand for presentation of the superantigen staphylococcal enterotoxin B to T cells. Proc. Natl. Acad. Sci. USA 93:3037-3042.
13. Harding, C. V. 1996. Class II antigen processing: analysis of compartments and functions. Crit. Rev. Immunol. 16:13-29.
14. Hudson, K. R., R. E. Tiedemann, R. G. Urban, S. C. Lowe, J. L. Strominger, and J. D. Fraser. 1995. Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II. J. Exp. Med. 182:711-720.
15. Jardetzky, T. S., J. H. Brown, J. C. Gorga, L. J. Stern, R. G. Urban, Y. I. Chi, C. Stauffacher, J. L. Strominger, and D. C. Wiley. 1994. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368:711-718.
16. Kim, J., R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 266:1870-1874.
17. Kozono, H., D. Parker, J. White, P. Marrack, and J. Kappler. 1995. Multiple binding sites for bacterial superantigens on soluble class II MHC molecules. Immunity 3:187-196.
18. Krupka, H. I., B. W. Segelke, R. G. Ulrich, S. Ringhofer, M. Knapp, and B. Rupp. 2002. Structural basis for abrogated binding between staphylococcal enterotoxin A superantigen vaccine and MHC-IIα. Protein Sci. 11:642-651.
19. Lanzavecchia, A., P. A. Reid, and C. Watts. 1992. Irreversible association of peptides with class II MHC molecules in living cells. Nature 357:249-252.
20. Lavoie, P. M., J. Thibodeau, F. Erard, and R. P. Sekaly. 1999. Understanding the mechanism of action of bacterial superantigens from a decade of research. Immunol. Rev. 168:257-269.
21. Lesley, J., R. Schulte, and J. Woods. 1989. Modulation of transferrin receptor expression and function by anti-transferrin receptor antibodies and antibody fragments. Exp. Cell Res. 182:215-233.
22. Li, Y., H. Li, N. Dimasi, J. K. McCormick, R. Martin, P. Schuck, P. M. Schlievert, and R. A. Mariuzza. 2001. Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. Immunity 14:93-104.
23. Llewelyn, M., and J. Cohen. 2002. Superantigens: microbial agents that corrupt immunity. Lancet Infect. Dis. 2:156-162.
24. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248:705-711.
25. Mollick, J. A., M. Chintagumpala, R. G. Cook, and R. R. Rich. 1991. Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotype. J. Immunol. 146:463-468.
26. Montecucco, C., G. Schiavo, Z. Gao, E. Bauerlein, P. Boquet, and B. R. DasGupta. 1988. Interaction of botulinum and tetanus toxins with the lipid bilayer surface. Biochem. J. 251:379-383.
27. Morton, P. A., M. L. Zacheis, K. S. Giacoletto, J. A. Manning, and B. D. Schwartz. 1995. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells. J. Immunol. 154:137-150.
28. Papageorgiou, A. C., and K. R. Acharya. 2000. Microbial superantigens: from structure to function. Trends Microbiol. 8:369-375.
29. Petersson, K., M. Hakansson, H. Nilsson, G. Forsberg, L. A. Svensson, A. Liljas, and B. Walse. 2001, Crystal structure of a superantigen bound to MHC class II displays zinc and peptide dependence. EMBO J. 20:3306-3312.
30. Petersson, K., M. Thunnissen, G. Forsberg, and B. Walse. 2002. Crystal structure of a SEA variant in complex with MHC class II reveals the ability of SEA to crosslink MHC molecules. Structure 10:1619-1626.
31. Pinet, V., M. Vergelli, R. Martin, O. Bakke, and E. O. Long. 1995. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 375:603-606.
32. Pless, D. D., E. R. Torres, E. K. Reinke, and S. Bavari. 2001. High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A. Infect. Immun. 69:570-574.
33. Posnett, D. N. 1993. Do superantigens play a role in autoimmunity? Semin. Immunol. 5:65-72.
34. Proft, T., V. L. Arcus, V. Handley, E. N. Baker, and J. D. Fraser. 2001. Immunological and biochemical characterization of streptococcal pyrogenic exotoxins I and J (SPE-I and SPE-J) from Streptococcus pyogenes. J. Immunol. 166:6711-6719.
35. Qiu, Y., X. Xu, A. Wandinger-Ness, D. P. Dalke, and S. K. Pierce. 1994. Separation of subcellular compartments containing distinct functional forms of MHC class II. J. Cell Biol. 125:595-605.
36. Redpath, S., S. M. Alam, C. M. Lin, A. M. O'Rourke, and N. R. J. Gascoigne. 1999. Trimolecular interaction of TCR with MHC class II and bacterial superantigen shows a similar affinity to MHC-peptide ligands. J. Immunol. 163:6-10.
37. Roche, P. A., C. L. Teletski, E. Stang, O. Bakke, and E. O. Long. 1993. Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. Proc. Natl. Acad. Sci. USA 90:8581-8585.
38. Rogers, T. J., and L. Zhang. 1997. Structural basis for the interaction of superantigen with the alternative superantigen-binding receptor p85. Mol. Immunol. 34:263-272.
39. Roussel, A., B. F. Anderson, H. M. Baker, J. D. Fraser, and E. N. Baker. 1997. Crystal structure of the streptococcal superantigen SPE-C: dimerization and zinc binding suggest a novel mode of interaction with MHC class II molecules. Nat. Struct. Biol. 4:635-643.
40. Schlievert, P. M. 1986. Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet i:1149-1150.
41. Scholl, P. R., A. Diez, and R. S. Geha. 1989. Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules. J. Immunol. 143:2583-2588.
42. Scholl, P., A. Diez, W. Mourad, J. Parsonnet, R. S. Geha, and T. Chatila. 1989. Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 86:4210-4214.
43. Schwab, J. H., R. R. Brown, S. K. Anderle, and P. M. Schlievert. 1993. Superantigen can reactivate bacterial cell wall-induced arthritis. J. Immunol. 150:4151-4159.
44. Seth, A., L. J. Stern, T. H. Ottenhoff, I. Engel, M. J. Owen, J. R. Lamb, R. D. Klausner, and D. C. Wiley. 1994. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro. Nature 369:324-327.
45. Singh, B. R. 2000. Intimate details of the most poisonous poison. Nat. Struct. Biol. 7:617-619.
46. Song, W., H. Cho, P. Cheng, and S. K. Pierce. 1995. Entry of B cell antigen receptor and antigen into class II peptide-loading compartment is independent of receptor cross-linking. J. Immunol. 155:4255-4263.
47. Storrie, B., and E. A. Madden. 1990. Isolation of subcellular organelles. Methods Enzymol. 182:203-225.
48. Sundberg, E. J., Y. Li, and R. A. Mariuzza. 2002. So many ways of getting in the way: diversity in the molecular architecture of superantigen-dependent T-cell signaling complexes. Curr. Opin. Immunol. 14:36-44.
49. Tang, Q., and M. Edidin. 2003. Lowering the barriers to random walks on the cell surface. Biophys. J. 84:400-407.
50. Thyagarajan, R., N. Arunkumar, and W. J. Song. 2003. Polyvalent antigens stabilize B-cell antigen receptor surface signaling microdomains. J. Immunol. 170:6099-6106.
51. Tiedemann, R. E., and J. D. Fraser. 1996. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T-cell activation. J. Immunol. 157:3958-3966.
52. Touster, O., N. N. Aronson, Jr., J. T. Dulaney, and H. Hendrickson. 1970. Isolation of rat liver plasma membranes. Use of nucleotide pyrophosphatase and phosphodiesterase I as marker enzymes. J. Cell Biol. 47:604-618.
53. Ulrich, R. G., S. Bavari, and M. A. Olson. 1995. Bacterial superantigens in human disease: structure, function, and diversity. Trends Microbiol. 3:463-468.
54. Ulrich, R. G., S. Bavari, and M. A. Olson. 1995. Staphylococcal enterotoxins A and B share a common structural motif for binding class II major histocompatibility complex molecules. Nat. Struct. Biol. 2:554-560.
55. West, M. A., J. M. Lucocq, and C. Watts. 1994. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature 369:147-151.